Study S002257

A Multi-centre, Prospective, Non-interventional Single-arm Study Investigating Clinical Parameters Associated With the Use of Once-daily Oral Semaglutide in a Real-world Adult Population With Type 2 Diabetes in Germany

ClinicalTrials.gov record

Registration

Registration: NCT05473286
Acronym: PIONEER REAL
Study type: OBSERVATIONAL
Status: WITHDRAWN
Enrollment: 0
Start: 2022-09-30
Primary completion: 2024-05-16
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Oral Semaglutide
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Change in Glycated haemoglobin (HbA1c ) [From baseline (week 0) to End of Study visit (V3) (week 34-44)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.